FIELD: medicine, pharmacy. SUBSTANCE: invention relates to preparation developed on the base of Bacillis live culture that has recombinant strain of B. subtilis producing human α-2-interferon and B. licheniformis live culture in their definite content and usual vehicle. Preparation ensures to treat patients with viral infections (hepatitis, herpes, encephalitis and others), bacterial infections (enteritis, colitis, chlamydiosis, vaginosis) and immunodeficiency states by noninvasive methods. EFFECT: enhanced effectiveness of biopharmaceutical preparation, broadened arsenal of agents for control of bacterial, viral infections and immunodeficiency states. 7 cl, 4 tbl, 33 ex
